参考文献/References:
［参 考 文 献］
［1］ Wilke T, Groth A, Mueller S, et al. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients［J］.Europace, 2013, 15: 486-493.
［2］ Dzeshka MS, Lip GY. Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation［J］. Expert Opin Drug Saf, 2015, 14: 45-62.
［3］ Marijon E, Le Heuzey JY, Connolly S, et al. Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study［J］. Circulation, 2013, 128: 2192-2201.
［4］ Alli O, Holmes DR Jr. Left atrial appendage occlusion for stroke prevention［J］. Curr Probl Cardiol, 2012, 37: 405-441.
［5］ Madden JL. Resection of the left auricular appendix; a prophylaxis for recurrent arterial emboli［J］. J Am Med Assoc, 1949, 140: 769-772.
［6］ Healey JS, Crystal E, Lamy A, et al. Left atrial appendage occlusion study（LAAOS）: results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke［J］. Am Heart J, 2005, 150: 288-293.
［7］ Dawson AG, Asopa S, Dunning J. Should patients undergoing cardiac surgery with atrial fibrillation have left atrial appendage exclusion?［J］. Interact Cardiovasc Thorac Surg, 2010, 10: 306-311.
:［8］ 周 勇， 蒋逸风． 经皮穿刺左心耳闭合装置的研制及临床应用［J］． 介入放射学杂志， 2013， 22： 698-700．
［9］ Don CW, Fuller CJ, Reisman M. Transcatheter left atrial appendage occlusion. Cardiol Clin, 2013, 31: 363-384.
［10］ Di Biase L, Santangeli P, Anselmino M, et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study［J］. J Am Coll Cardiol, 2012, 60: 531-538.
［11］ Agner BF, Kühl JT, Linde JJ, et al. Assessment of left atrial volume and function in patients with permanent atrial fibrillation: comparison of cardiac magnetic resonance imaging, 320-slice multi-detector computed tomography, and transthoracic echocar-diography［J］. Eur Heart J Cardiovasc Imaging, 2014, 15: 532-540.
［12］ Fatkin D, Kelly RP, Feneley MP. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo［J］. J Am Coll Cardiol, 1994, 23: 961-969.
［13］ Park YM, Kim MN, Choi JI, et al. Intra-procedural imaging of the left atrium and pulmonary veins with rotational angiography: a comparison of anatomy obtained by pre-procedural cardiac computed tomography and trans-thoracic echocardiography［J］. Int J Cardiovasc Imaging, 2013, 29: 1423-1432.
［14］ 杨志宏， 吴 弘， 胡建强， 等． 左心耳造影方法的建立及最佳投照体位的研究［J］． 介入放射学杂志， 2006， 15： 494-496．
［15］ Nakai T, Lesh MD, Gerstenfeld EP, et al. Percutaneous left atrial appendage occlusion（PLAATO） for preventing cardioembolism: first experience in canine model［J］. Circulation, 2002, 105: 2217-2222.
［16］ Sievert H, Lesh MD, Trepels T, et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience［J］. Circulation, 2002, 105: 1887-1889.
［17］ Ostermayer SH, Reisman M, Kramer PH, et al. Percutaneous left atrial appendage transcatheter occlusion（PLAATO system） to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials［J］. J Am Coll Cardiol, 2005, 46: 9-14.
［18］ Block PC, Burstein S, Casale PN, et al. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO （Percutaneous Left Atrial Appendage Transcatheter Occlusion） Study［J］. JACC Cardiovasc Interv, 2009, 2: 594-600.
［19］ Bayard YL, Omran H, Neuzil P, et al. PLAATO （Percutaneous Left Atrial Appendage Transcatheter Occlusion） for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study［J］. EuroIntervention, 2010, 6: 220-226.
［20］ Whitlock RP, Hanif H, Danter M. Nonpharmacologic approaches to stroke prevention in atrial fibrillation. Can J Cardiol, 2013, 29（7 Suppl）: S79-S86.
［21］ Sick PB, Schuler G, Hauptmann KE, et al. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation［J］. J Am Coll Cardiol, 2007, 49: 1490-1495.
［22］ Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non- inferiority trial［J］. Lancet, 2009, 374: 534-542.
［23］ Reddy VY, Doshi SK, Sievert H, et al. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF（Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation） Trial［J］. Circulation, 2013, 127: 720-729.
［24］ Reddy VY, Holmes D, Doshi SK, et al. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF （PROTECT AF） clinical trial and the Continued Access Registry［J］. Circulation, 2011, 123: 417-424.
［25］ Massumi A, Chelu MG, Nazeri A, et al. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation［J］. Am J Cardiol, 2013, 111: 869-873.
［26］ Stone D, Byrne T, Pershad A. Early results with the LARIAT device for left atrial appendage exclusion in patients with atrial fibrillation at high risk for stroke and anticoagulation［J］. Catheter Cardiovasc Interv, 2015, 86: 121-127.
［27］ Lam YY, Yip GW, Yu CM, et al. Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience［J］. Catheter Cardiovasc Interv, 2012, 79: 794-800.
［28］ Park JW, Bethencourt A, Sievert H, et al. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience［J］. Catheter Cardiovasc Interv, 2011, 77: 700-706.
［29］ Plicht B, Konorza TF, Kahlert P, et al. Risk factors for thrombus formation on the Amplatzer Cardiac Plug after left atrial appendage occlusion［J］. JACC Cardiovasc Interv, 2013, 6: 606-613.
［30］ Freixa X, Chan JL, Tzikas A, et al. The amplatzer? cardiac plug 2 for left atrial appendage occlusion: novel features and first-in-man experience［J］. EuroIntervention, 2013, 8: 1094-1098.
［31］ Lam YY. A new left atrial appendage occluder（Lifetech LAmbre Device） for stroke prevention in atrial fibrillation［J］. Cardiovasc Revasc Med, 2013, 14: 134-136.
［32］ Bruce CJ, Stanton CM, Asirvatham SJ, et al. Percutaneous epicardial left atrial appendage closure: intermediate-term results［J］. J Cardiovasc Electrophysiol, 2011, 22: 64-70.
［33］ Toumanides S, Sideris EB, Agricola T, et al. Transcatheter patch occlusion of the left atrial appendage using surgical adhesives in high-risk patients with atrial fibrillation［J］. J Am Coll Cardiol, 2011, 58: 2236-2240.
相似文献/References:
[1]张 琳,黄学全,王健,等.自主研发电化学治疗同轴电极与传统针式电极电解效应的对比研究[J].介入放射学杂志,2012,(02):148.
ZHANG Lin,HUANG Xue-quan,WANG Jian,et al.The electrolytic effect in electrochemotherapy: a comparative study between self-prepared coaxial electrode and conventional needle electrode[J].journal interventional radiology,2012,(09):148.
[2]赵 玮,王伟中,陈莹,等.耳部动静脉畸形供血动脉的血管造影研究[J].介入放射学杂志,2012,(02):103.
ZHAO Wei,WANG Wei-zhong,CHEN Ying,et al.Angiographic findings of the feeding arteries of auricular arteriovenous malformations[J].journal interventional radiology,2012,(09):103.
[3]邹俊民,龙世娟,张振明. 改良髂内动脉化疗联合放疗治疗Ⅲ~Ⅳa期 子宫颈癌32例[J].介入放射学杂志,2012,(02):123.
ZOU Jun-min,LONG Shi-Juan,ZHANG Zheng-ming..Improved internal iliac artery chemotherapy combined with radiotherapy for the treatment of stage Ⅲ-Ⅳa cervical cancers[J].journal interventional radiology,2012,(09):123.
[4]王昌明,李 选,宋世兵,等.肝门部胆道引流管折叠技术在肝移植后胆道非吻合口狭窄治疗中的应用[J].介入放射学杂志,2012,(02):136.
WANG Chang-ming,LI Xuan,SONG Shi-bing,et al.The application of biliary catheter folding technique in the treatment of hilar nonanastomotic biliary strictures after orthotopic liver transplantation[J].journal interventional radiology,2012,(09):136.
[5]赵玉峰,孙玉琴,韩晓静,等. 输卵管介入再通术后受孕时机的研究[J].介入放射学杂志,2012,(02):158.
ZHAO Yu-feng,SUN Yu-qin,HAN Xiao-jing,et al.The optimal time for conception after fallopian tube recanalization therapy[J].journal interventional radiology,2012,(09):158.
[6]含 笑,曹建民,史东宏,等.吉西他滨、顺铂动静脉联合化疗治疗晚期非小细胞肺癌的近期疗效分析[J].介入放射学杂志,2012,(02):119.
HAN Xiao,CAO Jian-min,SHI Dong-hong,et al.Bronchial artery infusion of Gemcitabine and Cisplatin combined with systemic chemotherapy for advanced non-small cell lung cancer: its short-term efficacy[J].journal interventional radiology,2012,(09):119.
[7]姚雪松,李 槐.不可手术切除的肝细胞癌的疗效评价标准——改良ＲＥＣＩＳＴ标准更可靠[J].介入放射学杂志,2012,(03):177.
. Ｔｈｅｒａｐｅｕｔｉｃ ｅｖａｌｕａｔｉｏｎ ｃｒｉｔｅｒｉｏｎ ｏｆ ｉｎｏｐｅｒａｂｌｅ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａｓ： ｍｏｄｉｆｉｅｄ ＲＥＣＩＳＴ ａｓ ａ ｍｏｒｅ ｒｅｌｉａｂｌｅ ｓｔａｎｄａｒｄ[J].journal interventional radiology,2012,(09):177.
[8]齐 立,李慎茂,俸军林,等. 动脉溶栓与机械碎栓联合动脉溶栓的对比分析[J].介入放射学杂志,2012,(03):180.
,,et al. Ｃｏｍｐａｒｉｓｏｎ ｏｆ ｔｈｅ ｔｈｅｒａｐｅｕｔｉｃ ｅｆｆｉｃａｃｙ ｂｅｔｗｅｅｎ ｓｉｍｐｌｅ ａｒｔｅｒｉａｌ ｔｈｒｏｍｂｏｌｙｓｉｓ ａｎｄ ｍｅｃｈａｎｉｃａｌ ｔｈｒｏｍｂｅｃｔｏｍｙ ｃｏｍｂｉｎｅｄ ｗｉｔｈ ａｒｔｅｒｉａｌ ｔｈｒｏｍｂｏｌｙｓｉｓ ｆｏｒ ａｃｕｔｅ ｃｅｒｅｂｒａｌ ｉｎｆａｒｃｔｉｏｎ ａｔ ｉｔｓ ｕｌｔｒａｅａｒｌｙ ｓｔａｇｅ[J].journal interventional radiology,2012,(09):180.
[9]石 潆,赵 卫,沈 进,等.脑动静脉畸形栓塞治疗术并发颅内出血的原因及处理[J].介入放射学杂志,2012,(03):185.
,,et al.Ｉｎｔｒａｃｒａｎｉａｌ ｈｅｍｏｒｒｈａｇｅ ｄｕｅ ｔｏ ｅｍｂｏｌｉｚａｔｉｏｎ ｔｈｅｒａｐｙ ｆｏｒ ｃｅｒｅｂｒａｌ ａｒｔｅｒｉｏｖｅｎｏｕｓ ｍａｌｆｏｒｍａｔｉｏｎ： ｉｔｓ ｃａｕｓｅｓ ａｎｄ ｍａｎａｇｅｍｅｎｔ [J].journal interventional radiology,2012,(09):185.
[10]周 慷,李晓光,金征宇,等.清宫术前子宫动脉化疗栓塞术治疗瘢痕妊娠的疗效分析[J].介入放射学杂志,2012,(03):190.
,,et al.Ｔｈｅｒａｐｅｕｔｉｃ ａｎａｌｙｓｉｓ ｏｆ ｂｉｌａｔｅｒａｌ ｕｔｅｒｉｎｅ ａｒｔｅｒｙ ｃｈｅｍｏｅｍｂｏｌｉｚａｔｉｏｎ ｐｅｒｆｏｒｍｅｄ ｂｅｆｏｒｅ ｕｔｅｒｉｎｅ ｄｉｌａｔｉｏｎ ａｎｄ ｃｕｒｅｔｔａｇｅ ｆｏｒ ｃｅｓａｒｅａｎ ｓｃａｒ ｐｒｅｇｎａｎｃｙ [J].journal interventional radiology,2012,(09):190.